| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |